Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study.
Buziau AM, Law PJ, Blokland G, Schalkwijk C, Scheijen J, Simons P, van der Kallen C, Eussen S, Dagnelie PC, van Greevenbroek M, Houlston RS, Wesselius A, Went M, Stehouwer C, Brouwers MC. Buziau AM, et al. Among authors: schalkwijk c. Gut. 2023 Mar;72(3):604-606. doi: 10.1136/gutjnl-2021-326299. Epub 2022 May 10. Gut. 2023. PMID: 35537810 No abstract available.
Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Nanayakkara PW, Teerlink T, Stehouwer CD, Allajar D, Spijkerman A, Schalkwijk C, ter Wee PM, van Guldener C. Nanayakkara PW, et al. Among authors: schalkwijk c. Kidney Int. 2005 Nov;68(5):2230-6. doi: 10.1111/j.1523-1755.2005.00680.x. Kidney Int. 2005. PMID: 16221223 Free article. Clinical Trial.
Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial.
Vermeulen EG, Rauwerda JA, van den Berg M, de Jong SC, Schalkwijk C, Twisk JW, Stehouwer CD. Vermeulen EG, et al. Among authors: schalkwijk c. Eur J Clin Invest. 2003 Mar;33(3):209-15. doi: 10.1046/j.1365-2362.2003.01135.x. Eur J Clin Invest. 2003. PMID: 12641538 Clinical Trial.
Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study.
Barutta F, Bellini S, Guarrera S, Matullo G, Schalkwijk C, Stehouwer CD, Chaturvedi N, Soedamah-Muthu SS, Durazzo M, Gruden G. Barutta F, et al. Among authors: schalkwijk c. Diabetes Res Clin Pract. 2022 Aug;190:109987. doi: 10.1016/j.diabres.2022.109987. Epub 2022 Jul 9. Diabetes Res Clin Pract. 2022. PMID: 35820565 Free article.
537 results